{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:40Z","timestamp":1792788640377,"version":"4.5.0"},"update-to":[{"DOI":"10.1016\/j.jtcvs.2026.03.619","type":"removal","label":"Removal","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtcvs.2026.03.619","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:35:24Z","timestamp":1777887324000},"page":"487-509.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["TEMPORARY REMOVAL: 2026 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Diagnosis and management of heparin-induced thrombocytopenia in cardiac surgery patients"],"prefix":"10.1016","volume":"172","author":[{"given":"Subhasis","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia I.","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Crow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore E.","family":"Warkentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha P.","family":"Mims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh C.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra","family":"Cangut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim S.","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arabesque","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian F.","family":"Holler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leora B.","family":"Balsam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jtcvs.2026.03.619_bib1","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"2 Suppl","key":"10.1016\/j.jtcvs.2026.03.619_bib2","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jtcvs.2024.07.048","volume":"169","author":"Milojevic","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jtcvs.2017.01.003","article-title":"The American Association for Thoracic Surgery\/Society of Thoracic Surgeons position statement on developing clinical practice documents","volume":"153","author":"Bakaeen","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1160\/TH16-03-0230","article-title":"Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients","volume":"116","author":"Selleng","year":"2016","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1213\/ANE.0000000000002613","article-title":"The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology: clinical practice guidelines\u2014anticoagulation during cardiopulmonary bypass","volume":"126","author":"Shore-Lesserson","year":"2018","journal-title":"Anesth Analg"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.03.619_bib8","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/jth.15826","article-title":"Temporal presentations of heparin-induced thrombocytopenia following cardiac surgery: a single-center, retrospective cohort study","volume":"20","author":"Warkentin","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.athoracsur.2019.10.039","article-title":"Thrombocytopenia after cardiopulmonary bypass is associated with increased morbidity and mortality","volume":"110","author":"Griffin","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s13019-024-03017-x","article-title":"Analysis of influencing factors and construction of risk prediction model for postoperative thrombocytopenia in critically ill patients with heart disease","volume":"19","author":"Song","year":"2024","journal-title":"J Cardiothorac Surg"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.619_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamasurg.2019.1153","article-title":"Guidelines for perioperative care in cardiac surgery: enhanced recovery after surgery society recommendations","volume":"154","author":"Engelman","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jtcvs.2026.03.619_bib12","article-title":"Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib13","article-title":"Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients","volume":"4","author":"Junqueira","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1016\/j.jtcvs.2026.03.619_bib14","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2015-07-660001","article-title":"Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program","volume":"127","author":"McGowan","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.amjcard.2010.10.020","article-title":"Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery","volume":"107","author":"Bucci","year":"2011","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0003-4975(03)00756-2","article-title":"Heparin-induced thrombocytopenia and cardiac surgery","volume":"76","author":"Warkentin","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.03.619_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-0037-1602664","article-title":"Heparin-induced thrombocytopenia in cardiac surgery patients","volume":"43","author":"Pishko","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.03.619_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MBC.0b013e3283494b3c","article-title":"Protamine reversal of low molecular weight heparin: clinically effective?","volume":"22","author":"van Veen","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.03.619_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.103191","article-title":"Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparin","volume":"9","author":"van Haaps","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/hematology.2024000566","article-title":"Practical guide to the diagnosis and management of heparin-induced thrombocytopenia","volume":"2024","author":"May","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/hematology.2021000289","article-title":"Heparin-induced thrombocytopenia and cardiovascular surgery","volume":"2021","author":"Pishko","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.semtcvs.2018.10.011","article-title":"Heparin-induced thrombocytopenia and cardiac surgery","volume":"31","author":"Solanki","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jtcvs.2026.03.619_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1538-7836.2011.04322.x","article-title":"HIT paradigms and paradoxes","volume":"9","author":"Warkentin","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.03.619_bib24","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1538-7836.2010.03880.x","article-title":"Non-necrotizing heparin-induced skin lesions and the 4T's score","volume":"8","author":"Warkentin","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtcvs.2026.03.619_bib25","series-title":"Heparin-Induced Thrombocytopenia","first-page":"89","article-title":"Differential diagnosis of heparin-induced thrombocytopenia and scoring systems","author":"Greinacher","year":"2012"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.jvca.2011.11.009","article-title":"Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients","volume":"26","author":"Piednoir","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6-7","key":"10.1016\/j.jtcvs.2026.03.619_bib27","first-page":"563","article-title":"Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery","volume":"100","author":"Pouplard","year":"2007","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.13533","article-title":"The association of anti-platelet factor 4\/heparin antibodies with early and delayed thromboembolism after cardiac surgery","volume":"15","author":"Welsby","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11239-015-1236-0","article-title":"Consequences of treating false positive heparin-induced thrombocytopenia","volume":"40","author":"Marler","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib30","first-page":"106","article-title":"Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach","volume":"40","author":"Cuker","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.03.619_bib31","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1538-7836.2004.00949.x","article-title":"Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass","volume":"2","author":"Lillo-Le Lou\u00ebt","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"22","key":"10.1016\/j.jtcvs.2026.03.619_bib32","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/bloodadvances.2018023077","article-title":"Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia","volume":"2","author":"Pishko","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcrc.2013.12.010","article-title":"Assessment of a modified 4T scoring system for heparin-induced thrombocytopenia in critically ill patients","volume":"29","author":"Fiorenza","year":"2014","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11239-014-1123-0","article-title":"Over-testing for heparin induced thrombocytopenia in hospitalized patients","volume":"40","author":"Chaturvedi","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0035-1564840","article-title":"Diagnostic performance of a new rapid lateral flow immunoassay in patients suspected of heparin-induced thrombocytopenia and its clinical consequences","volume":"42","author":"Berro\u00ebta","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MBC.0b013e328344f7e9","article-title":"Performance of a new, rapid, automated immunoassay for the detection of anti-platelet factor 4\/heparin complex antibodies","volume":"22","author":"Davidson","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ijlh.13029","article-title":"Evaluation of a rapid and automated heparin-induced thrombocytopenia immunoassay","volume":"41","author":"Refaai","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"20","key":"10.1016\/j.jtcvs.2026.03.619_bib39","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtcvs.2026.03.619_bib40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ajh.21032","article-title":"What is the potential for overdiagnosis of heparin-induced thrombocytopenia?","volume":"82","author":"Lo","year":"2007","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3786","article-title":"Accuracy of diagnosing heparin-induced thrombocytopenia","volume":"7","author":"Larsen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjh.19180","article-title":"Diagnosis and management of heparin-induced thrombocytopenia: third edition","volume":"204","author":"Arachchillage","year":"2024","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib43","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V96.3.846","article-title":"Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range","volume":"96","author":"Greinacher","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib44","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.03.619_bib45","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/jth.14587","article-title":"The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia","volume":"17","author":"Pishko","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib46","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/jth.13692","article-title":"Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"15","author":"Husseinzadeh","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib47","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2015-07-661215","article-title":"Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"127","author":"Nagler","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib48","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1160\/TH15-06-0523","article-title":"Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"115","author":"Sun","year":"2016","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.jtcvs.2026.03.619_bib49","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood-2018-04-847483","article-title":"High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT","volume":"132","author":"Warkentin","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtcvs.2026.03.619_bib50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.thromres.2017.03.010","article-title":"Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL\u00ae HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia","volume":"153","author":"Warkentin","year":"2017","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/jth.13565","article-title":"Inappropriate documentation of heparin allergy in the medical record because of misdiagnosis of heparin-induced thrombocytopenia: frequency and consequences","volume":"15","author":"McMahon","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.14-1417","article-title":"The role for optical density in heparin-induced thrombocytopenia: a cohort study","volume":"148","author":"Chan","year":"2015","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.619_bib53","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays","volume":"6","author":"Warkentin","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib63","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jtcvs.2011.07.068","article-title":"Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit","volume":"143","author":"Demma","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/EJA.0000000000000707","article-title":"European guidelines on perioperative venous thromboembolism prophylaxis: intensive care","volume":"35","author":"Duranteau","year":"2018","journal-title":"Eur J Anaesthesiol"},{"issue":"12","key":"10.1016\/j.jtcvs.2026.03.619_bib65","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1592\/phco.30.12.1229","article-title":"Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia","volume":"30","author":"Skrupky","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.619_bib66","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1053\/j.jvca.2019.08.022","article-title":"Role of bivalirudin for anticoagulation in adult perioperative cardiothoracic practice","volume":"34","author":"Erdoes","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib67","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1160\/TH15-11-0847","article-title":"Argatroban pharmacokinetics and pharmacodynamics in critically ill cardiac surgical patients with suspected heparin-induced thrombocytopenia","volume":"115","author":"Keyl","year":"2016","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.jtcvs.2026.03.619_bib68","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/j.1538-7836.2011.04487.x","article-title":"Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series","volume":"9","author":"Warkentin","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib69","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/ejcts\/ezw200","article-title":"Presentation, management and outcome of heparin-induced thrombocytopenia after valvular heart surgery","volume":"50","author":"Arangalage","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib70","first-page":"576","article-title":"Heparin-induced thrombocytopenia","volume":"21","author":"Warkentin","year":"2015","journal-title":"Curr Opin Crit Care"},{"issue":"9","key":"10.1016\/j.jtcvs.2026.03.619_bib71","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","article-title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","volume":"130","author":"Warkentin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtcvs.2026.03.619_bib72","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.avsg.2024.05.005","article-title":"Heparin-induced thrombocytopenia (HIT) in the direct oral anticoagulants (DOAC) era","volume":"108","author":"Mahoney","year":"2024","journal-title":"Ann Vasc Surg"},{"issue":"9","key":"10.1016\/j.jtcvs.2026.03.619_bib73","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","article-title":"The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11239-005-1849-9","article-title":"Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR)","volume":"19","author":"Bartholomew","year":"2005","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib75","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/hematology.2024000564","article-title":"Approaches to management of HIT in complex scenarios, including cardiac surgery","volume":"2024","author":"Adeoye","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"21","key":"10.1016\/j.jtcvs.2026.03.619_bib76","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.3390\/jcm12216921","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"12","author":"Warkentin","year":"2023","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.619_bib77","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2019.1636645","article-title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","volume":"12","author":"Warkentin","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.03.619_bib78","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1111\/trf.16018","article-title":"Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: a systematic review","volume":"60","author":"Onuoha","year":"2020","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.619_bib79","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ajh.24759","article-title":"Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia","volume":"92","author":"Kuter","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtcvs.2026.03.619_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/1076029621996473","article-title":"Bleeding and thrombotic adverse events in hospitalized patients under empiric treatment for suspected heparin-induced thrombocytopenia while awaiting confirmatory testing","volume":"27","author":"Dykes","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"issue":"20","key":"10.1016\/j.jtcvs.2026.03.619_bib81","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1182\/bloodadvances.2020002963","article-title":"Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses","volume":"4","author":"Morgan","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtcvs.2026.03.619_bib82","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/JBM.S38762","article-title":"Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II","volume":"5","author":"Grouzi","year":"2014","journal-title":"J Blood Med"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib83","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1538-7836.2010.03861.x","article-title":"Outcomes after platelet transfusion in patients with heparin-induced thrombocytopenia","volume":"8","author":"Refaai","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.03.619_bib84","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2025.7529","article-title":"Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines","volume":"334","author":"Metcalf","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib85","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/2279-042X.155754","article-title":"Usefulness of Danaparoid sodium in patients with heparin-induced thrombocytopenia after cardiac surgery","volume":"4","author":"Foroughinia","year":"2015","journal-title":"J Res Pharm Pract"},{"issue":"10","key":"10.1016\/j.jtcvs.2026.03.619_bib86","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1537-2995.2008.01822.x","article-title":"Platelet transfusions in heparin-induced thrombocytopenia: a report of four cases and review of the literature","volume":"48","author":"Hopkins","year":"2008","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib87","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.thromres.2009.04.002","article-title":"Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia","volume":"124","author":"Elalamy","year":"2009","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.619_bib88","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2002-05-1448","article-title":"Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia","volume":"101","author":"Hong","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib89","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib90","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1213\/ANE.0000000000005721","article-title":"Survey of practice pattern in patients with heparin-induced thrombocytopenia requiring cardiopulmonary bypass","volume":"133","author":"Wanat-Hawthorne","year":"2021","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib91","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.semtcvs.2019.10.002","article-title":"Novel use of cangrelor with heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia who require cardiovascular surgery: a case series","volume":"32","author":"Gernhofer","year":"2020","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0267659115583525","article-title":"Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery","volume":"31","author":"McNair","year":"2016","journal-title":"Perfusion"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/a-1336-6116","article-title":"GTH 2021 state of the art\u2014cardiac surgery: the perioperative management of heparin-induced thrombocytopenia in cardiac surgery","volume":"41","author":"Ranta","year":"2021","journal-title":"Hamostaseologie"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib94","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.jvca.2013.07.021","article-title":"Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: an analysis of the nationwide inpatient sample","volume":"28","author":"Seigerman","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib95","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1051\/ject\/2004364371","article-title":"Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant","volume":"36","author":"Baker","year":"2004","journal-title":"J Extra Corpor Technol"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1051\/ject\/201749049","article-title":"Bivalirudin as an alternative anticoagulant for cardiopulmonary bypass during adult cardiac surgery\u2014a change in practice","volume":"49","author":"Gatt","year":"2017","journal-title":"J Extra Corpor Technol"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib97","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1051\/ject\/200537296","article-title":"Use of bivalirudin as an anticoagulant during cardiopulmonary bypass","volume":"37","author":"Veale","year":"2005","journal-title":"J Extra Corpor Technol"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib98","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1213\/ANE.0b013e3181e9ead3","article-title":"Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation","volume":"111","author":"Wong","year":"2010","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/vox.13008","article-title":"Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin-induced thrombocytopenia","volume":"116","author":"Moreno-Duarte","year":"2021","journal-title":"Vox Sang"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib100","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezae354","article-title":"2024 EACTS\/EACTAIC\/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"67","author":"Wahba","year":"2025","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jtha.2024.10.035","article-title":"High-dose intravenous immunoglobulin G and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune heparin-induced thrombocytopenia","volume":"23","author":"Warkentin","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib102","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.jvca.2025.11.016","article-title":"Increased incidence of thrombosis in patients at risk of heparin-induced thrombocytopenia receiving epoprostenol for cardiac surgery","volume":"40","author":"Becher","year":"2026","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"16","key":"10.1016\/j.jtcvs.2026.03.619_bib103","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1182\/blood-2013-10-533083","article-title":"Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib104","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1213\/ANE.0b013e3182297031","article-title":"A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients","volume":"113","author":"Demma","year":"2011","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12959-024-00624-5","article-title":"Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis","volume":"22","author":"Song","year":"2024","journal-title":"Thromb J"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib106","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1097\/CCM.0000000000004261","article-title":"Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score","volume":"48","author":"Arachchillage","year":"2020","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.03.619_bib107","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1053\/j.jvca.2022.02.030","article-title":"The predictive value of the 4Ts and HEP score at recommended cutoffs in patients with mechanical circulatory support devices","volume":"36","author":"Kram","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib108","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/0267659119881266","article-title":"Predictive value of scoring tools in determining heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation","volume":"35","author":"Sullivan","year":"2020","journal-title":"Perfusion"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib109","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/jcm12010362","article-title":"Heparin-induced thrombocytopenia in patients undergoing venoarterial extracorporeal membrane oxygenation","volume":"12","author":"L\u00fcsebrink","year":"2023","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.jtcvs.2026.03.619_bib110","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s00134-018-5346-y","article-title":"Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study","volume":"44","author":"Kimmoun","year":"2018","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.619_bib111","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/03913988221106225","article-title":"Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation","volume":"45","author":"Hanna","year":"2022","journal-title":"Int J Artif Organs"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib112","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00134-020-06031-4","article-title":"Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis","volume":"46","author":"Jiritano","year":"2020","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.03.619_bib113","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1097\/CCM.0000000000001869","article-title":"Platelet count trends and prevalence of heparin-induced thrombocytopenia in a cohort of extracorporeal membrane oxygenator patients","volume":"44","author":"Sokolovic","year":"2016","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib114","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11239-021-02546-9","article-title":"Heparin-induced thrombocytopenia in extra-corporeal membrane oxygenation: epidemiology, outcomes, and diagnostic challenges","volume":"53","author":"Zaaqoq","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.jtcvs.2026.03.619_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272577","article-title":"Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation","volume":"17","author":"Lubnow","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib116","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/acs.2018.12.02","article-title":"Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes","volume":"8","author":"Choi","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"issue":"7","key":"10.1016\/j.jtcvs.2026.03.619_bib117","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/0267659119842056","article-title":"Heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation and the role of a heparin-bonded circuit","volume":"34","author":"Pabst","year":"2019","journal-title":"Perfusion"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib118","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/ALN.0000000000003044","article-title":"Anticoagulation management and antithrombin supplementation practice during veno-venous extracorporeal membrane oxygenation: a worldwide survey","volume":"132","author":"Protti","year":"2020","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MAT.0000000000001808","article-title":"Heparin versus bivalirudin for anticoagulation in adult extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"69","author":"Wieruszewski","year":"2023","journal-title":"ASAIO J"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.03.619_bib120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12959-022-00401-2","article-title":"Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"20","author":"M'Pembele","year":"2022","journal-title":"Thromb J"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib121","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors","volume":"86","author":"Weitz","year":"1990","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib122","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.CIR.97.6.544","article-title":"Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors","volume":"97","author":"Weitz","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib123","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MAT.0b013e318186a807","article-title":"Efficiency in extracorporeal membrane oxygenation\u2014cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity","volume":"54","author":"Lehle","year":"2008","journal-title":"ASAIO J"},{"issue":"9","key":"10.1016\/j.jtcvs.2026.03.619_bib124","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/MAT.0000000000002512","article-title":"Dosing reliability of direct thrombin inhibitors in extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"71","author":"Wieruszewski","year":"2025","journal-title":"ASAIO J"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.2011.03916.x","article-title":"Direct thrombin inhibitors","volume":"72","author":"Lee","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib126","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-2143(97)90115-3","article-title":"The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance","volume":"130","author":"Manson","year":"1997","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib127","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/molecules22061025","article-title":"From farm to pharma: an overview of industrial heparin manufacturing methods","volume":"22","author":"van der Meer","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jtcvs.2026.03.619_bib128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.thromres.2023.05.022","article-title":"Use of ecarin chromogenic assay during bivalirudin anticoagulation in adult extracorporeal membrane oxygenation","volume":"228","author":"Krauter","year":"2023","journal-title":"Thromb Res"},{"issue":"10","key":"10.1016\/j.jtcvs.2026.03.619_bib129","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/jth.14575","article-title":"Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: review of the literature and alternative anticoagulants","volume":"17","author":"Pollak","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtcvs.2026.03.619_bib130","article-title":"The efficacy and safety of bivalirudin versus heparin in the anticoagulation therapy of extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"13","author":"Ma","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib131","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/aor.12335","article-title":"Do we need heparin coating for extracorporeal membrane oxygenation? New concepts and controversial positions about coating surfaces of extracorporeal circuits","volume":"39","author":"Silvetti","year":"2015","journal-title":"Artif Organs"},{"issue":"4","key":"10.1016\/j.jtcvs.2026.03.619_bib132","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/08971900221089078","article-title":"Use of sodium bicarbonate purge solution in Impella devices for heparin-induced thrombocytopenia","volume":"36","author":"Al-Ayoubi","year":"2023","journal-title":"J Pharm Pract"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib133","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/aor.14497","article-title":"Sodium bicarbonate alters protein stability and blood coagulability in a simulated Impella purge gap model","volume":"47","author":"Ammann","year":"2023","journal-title":"Artif Organs"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.03.619_bib134","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/10600280221124156","article-title":"Analysis of bicarbonate-based purge solution in patients with cardiogenic shock supported via Impella ventricular assist device","volume":"57","author":"Bergen","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.03.619_bib135","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/phar.2629","article-title":"Optimizing anticoagulation for patients receiving Impella support","volume":"41","author":"Beavers","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.03.619_bib136","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/aor.14428","article-title":"Outcomes of systemic bivalirudin and sodium bicarbonate purge solution for Impella 5.5","volume":"47","author":"Bashline","year":"2023","journal-title":"Artif Organs"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.03.619_bib137","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11239-023-02852-4","article-title":"Sodium bicarbonate as a local adjunctive agent for limiting platelet activation, aggregation, and adhesion within cardiovascular therapeutic devices","volume":"56","author":"Ammann","year":"2023","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.03.619_bib138","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/ajhp\/zxad278","article-title":"A case series analysis of bicarbonate-based purge solution administration via Impella ventricular assist device","volume":"81","author":"Sigala","year":"2024","journal-title":"Am J Health Syst Pharm"}],"updated-by":[{"DOI":"10.1016\/j.jtcvs.2026.03.619","type":"removal","label":"Removal","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}},{"DOI":"10.1016\/j.jtcvs.2026.10.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000}}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326008895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326008895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:04:31Z","timestamp":1791500671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522326008895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022522326008895"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.03.619","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TEMPORARY REMOVAL: 2026 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Diagnosis and management of heparin-induced thrombocytopenia in cardiac surgery patients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.03.619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}